Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis

Status Recruiting

Clinical Trial Summary

The retinal vessels have been shown to reflect vascular changes inherent to systemic pathologies, even when no ocular disease is identified. As such, the eye's vasculature is ableto serve as a window to the vascular health of the human body and a means of assessing systemic endothelial function. Optical coherence tomography angiography (OCTA) employs optical means to image all the retinal vascular layers and the choroid, providing an extremely detailed image of the microvascular network in a fast, reproducible and totally non-invasive way. As such, it is currently the best non-invasive way of having an image of human capillaries. Recently, OCTA has been used to study the retinal vessels' structure and function in several cardiovascular diseases. As an example of its predictive potential, reduced retinal microvascular density has been associated with the cardiovascular risk profile in patients admitted to the hospital for an acute coronary syndrome. Recent studies have also shown the retinal microvasculature density to be reduced in patients with carotid artery disease (CAD), namely carotid stenosis, and that endarterectomy increases retinal flow and vessel density.

Clinical Trial Description

The authors hypothesize that FGF-23, GDF-15, VEGF-A, MMP-9 and retinal/choroidal microvascular density could predict cerebral ischemia, postoperative complications, long term major cardiovascular events and short term ophthalmologic alterations particularly in patients developing symptomatic neurologic ischemia after circulation shutdown. The purpose of this study is to compare different cardiac risk scores in carotid endarterectomy. The main aim of this study is to test the risk factors individually and determine its discriminatory ability. Combinations of traditional preoperative risk factors and scores will be evaluated to enhance the assessment of major adverse cardiac events in vascular surgery patients. Establish and validate biomarkers that improve the predictive value of current risk stratification models for patients benefiting from carotid revascularization, outperform existing biomarkers, and reach clinical application standards. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05623293
Study type	Observational
Source	Universidade do Porto
Contact	Joao Rocha-Neves, MD, MPH
Phone	+351910486230
Email	joaorochaneves@hotmail.com
Status	Recruiting
Phase
Start date	January 1, 2022
Completion date	December 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03631381` - Retrospective Study of Carotid Surgery in Dijon
Completed	`NCT05437991` - Ultrasonographic Morphology Assessment of Low-grade Carotid Stenosis	N/A
Completed	`NCT02722720` - Carotid Arteries Stenting Complications: Transradial Approach Versus Transfemoral	N/A
Completed	`NCT02336958` - Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration	N/A
Completed	`NCT02630862` - Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization	N/A
Completed	`NCT00536796` - Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets	N/A
Recruiting	`NCT05566301` - Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)
Completed	`NCT03303534` - Short-Term Endogenous Hydrogen Sulfide Upregulation	N/A
Completed	`NCT01480206` - Overlay of 3D Scans on Live Fluoroscopy for Endovascular Procedures in the Hybrid OR
Recruiting	`NCT05250349` - TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure
Recruiting	`NCT05845710` - Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)	N/A
Recruiting	`NCT01732523` - Predictive Value of Neovascularization Within Asymptomatic Carotis Stenosis on CEUS
Completed	`NCT01315288` - A Randomized Trial of Clinical Decision Making in Asymptomatic Carotid Stenosis	N/A
Withdrawn	`NCT00401921` - A Study of the Effects of Minocycline on Cognitive Function After Carotid Endarterectomy	Phase 2
Recruiting	`NCT01273350` - A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin)	N/A
Completed	`NCT03215563` - PET-MRI Imaging in Patients With Acute Neurovascular Syndrome
Completed	`NCT03215550` - PET-MRI Imaging in Patients With Symptomatic Carotid Artery Stenosis
Completed	`NCT04553549` - Safety and Feasibility of the Infinity Catheter for Radial Access
Completed	`NCT03596229` - Major Adverse Cardiac Events After Carotid Endarterectomy
Completed	`NCT04255316` - Modified Method of Eversion Carotid Endarterectomy in Patients With Extensive Atherosclerotic Disease of Carotid Bifurcation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.